Medication Reconciliation Failures in Children and Young Adults With Chronic Disease During Intensive and

Danielle D DeCourcey1, Melanie Silverman, Esther Chang

  • 11Department of Medicine, Boston Children's Hospital, Boston, MA. 2Department of Pharmacy, Boston Children's Hospital, Boston, MA. 3Center for Patient Safety and Quality Research, Boston Children's Hospital, Boston, MA. 4Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA.

Insights

Potentially harmful medication errors are common in critically ill children with chronic conditions. Current medication reconciliation processes are insufficient to prevent these unintentional discrepancies.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacovigilance
  • Patient Safety

Background:

  • Medication reconciliation is standard during hospital admission.
  • Unintentional medication discrepancies are a known cause of adverse drug events in adults with chronic illness.
  • Rates of such discrepancies in pediatric intensive care are unknown.

Purpose of the Study:

  • To determine the rate, type, timing, and predictors of potentially harmful unintentional medication discrepancies in children and young adults with chronic disease admitted to intensive care.
  • To assess the adequacy of current medication reconciliation processes in this population.

Main Methods:

  • Prospective observational cohort study.
  • Consecutive sample of 308 patients (<25 years old) with chronic disease admitted to intensive and intermediate care units.
  • Assessment of unintentional medication discrepancies with potential for harm, and associated patient/medication factors.

Main Results:

  • 284 (10%) of 2739 medication discrepancies were unintentional and potentially harmful (0.9/patient).
  • 45% were due to medication history errors, 55% to reconciliation errors; 66% occurred at admission, 45% were dosing errors.
  • Increased risk associated with more preadmission medications, chronic respiratory medications, and noninvasive ventilation.

Conclusions:

  • Potentially harmful unintentional medication discrepancies are common in critically ill children and young adults with chronic disease.
  • Both medication history taking and reconciliation processes contribute to these errors.
  • Current medication reconciliation processes are insufficient for this high-risk population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
335
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
559